These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11157034)

  • 21. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
    Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.
    Rosenthal DI; Sinard RJ; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch FM; Gazdar AF; Griener J; Frenkel EP; Carbone DP
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-67-S19-71. PubMed ID: 9427270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial.
    Hoffmann W; Belka C; Schmidberger H; Budach W; Bochtler H; Hess CF; Bamberg M
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):691-6. PubMed ID: 9240634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.
    Rosenthal DI; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch FM; Gazdar AF; Greiner J; Frenkel EF; Carbone DP
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-96-S12-100. PubMed ID: 9331130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose.
    Cerrotta A; Gardan G; Cavina R; Raspagliesi F; Stefanon B; Garassino I; Musumeci R; Tana S; De Palo G
    Eur J Gynaecol Oncol; 2002; 23(2):115-9. PubMed ID: 12013105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors.
    Rosenthal DI; Close LG; Lucci JA; Schold SC; Truelson J; Fathallah-Skaykh H; Kamen B; Vuitch FM; Gazdar AF; Griener J
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):13-7. PubMed ID: 7644923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of low dose weekly paclitaxel versus cisplatin with concurrent radiation in the treatment of locally advanced head and neck cancers.
    Jain RK; Kirar P; Gupta G; Dubey S; Gupta SK; Goyal J
    Indian J Cancer; 2009; 46(1):50-3. PubMed ID: 19282567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taxanes as radiosensitizers for head and neck cancer.
    Herscher LL; Cook J
    Curr Opin Oncol; 1999 May; 11(3):183-6. PubMed ID: 10328592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preclinical and clinical results in the simultaneous radiochemotherapy of head and neck tumors with Paclitaxel].
    Hoffmann W; Heinrich V; Belka C; Budach W; Schmidberger H; Bochtler H; Rodemann HP; Bamberg M
    Strahlenther Onkol; 1996 May; 172 Suppl 1():15-20. PubMed ID: 8633268
    [No Abstract]   [Full Text] [Related]  

  • 36. Concurrent Taxol and split-course accelerated radiotherapy for advanced head and neck cancer.
    Plasswilm L; Kirschner M; Sauer R
    Strahlenther Onkol; 1996 Oct; 172(10):573-9. PubMed ID: 8899009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.
    Birnbaum A; Dipetrillo T; Rathore R; Anderson E; Wanebo H; Puthwala Y; Joyce D; Safran H; Henderson D; Kennedy T; Ready N; Sio TT
    Am J Clin Oncol; 2010 Apr; 33(2):144-7. PubMed ID: 19786848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.
    Tishler RB; Busse PM; Norris CM; Rossi R; Poulin M; Thornhill L; Costello R; Peters ES; Colevas AD; Posner MR
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1001-8. PubMed ID: 10192347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.